ITI-333

DRUG3 trials

Sponsors

Intra-Cellular Therapies, Inc.

Conditions

Healthy Volunteers

Phase 1

Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ITI 333 in Healthy Volunteers

CompletedNCT04934124

Intra-Cellular Therapies, Inc.Healthy Volunteers

Start: 2020-12-23End: 2021-08-23Updated: 2023-03-14

A PET Study Following a Single Oral Dose of ITI-333 in Healthy Subjects

CompletedNCT05470101

Intra-Cellular Therapies, Inc.Healthy Volunteers

Start: 2022-07-26End: 2023-05-03Updated: 2025-09-10

Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ITI 333 in Healthy Volunteers

CompletedNCT05732194

Intra-Cellular Therapies, Inc.Healthy Volunteers

Start: 2023-01-18End: 2023-09-01Updated: 2026-06-09